Alana B. McNulty - Sep 7, 2021 Form 4 Insider Report for Janux Therapeutics, Inc. (JANX)

Role
Director
Signature
/s/ Maria Dobek, Attorney-in-Fact
Stock symbol
JANX
Transactions as of
Sep 7, 2021
Transactions value $
$0
Form type
4
Date filed
9/9/2021, 05:36 PM
Previous filing
Aug 27, 2021
Next filing
Jan 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JANX Stock Option (right to buy) Award $0 +30K $0.00 30K Sep 7, 2021 Common Stock 30K $29.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest in equal monthly installments over a three year period following September 7, 2021 (the "Grant Date") such that the option is fully vested on the third anniversary of the Grant Date.